NASDAQ: INSM
Insmed Inc Stock Ownership - Who owns Insmed?

Insider buying vs selling

Have Insmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William LewisChair and CEO2025-07-152,168$101.71
$220.51kSell
William LewisChair and CEO2025-07-154,492$102.66
$461.15kSell
William LewisChair and CEO2025-07-15170$103.32
$17.56kSell
Michael Alexander SmithChief Legal Officer2025-07-15933$102.51
$95.64kSell
William LewisChair and CEO2025-07-156,830$10.85
$74.11kBuy
Michael Alexander SmithChief Legal Officer2025-07-11748$96.41
$72.11kSell
Sara BonsteinChief Financial Officer2025-07-074,362$24.70
$107.74kBuy
Sara BonsteinChief Financial Officer2025-07-0723,565$26.43
$622.82kBuy
Sara BonsteinChief Financial Officer2025-07-0713,717$26.46
$362.95kBuy
Sara BonsteinChief Financial Officer2025-07-0735,583$95.66
$3.40MSell

1 of 25

INSM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INSM insiders and whales buy or sell their stock.

INSM Shareholders

What type of owners hold Insmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Richard S. Kollender12.04%21,924,540$2.29BInsider
Vanguard Group Inc10.03%18,268,122$1.91BInstitution
Blackrock Inc8.81%16,048,882$1.68BInstitution
Darwin Global Management Ltd8.45%15,397,975$1.61BInstitution
Price T Rowe Associates Inc7.10%12,923,541$1.35BInstitution
Capital International Investors3.95%7,198,485$752.89MInstitution
Jpmorgan Chase Co3.49%6,354,022$664.57MInstitution
State Street Corp3.16%5,747,293$601.11MInstitution
Baker Bros Advisors LP2.95%5,380,626$562.76MInstitution
Geode Capital Management LLC2.35%4,288,735$448.56MInstitution

1 of 3

INSM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INSM84.00%16.00%Net SellingNet Selling
RPRX56.29%17.86%Net BuyingNet Buying
SMMT7.21%92.79%Net BuyingNet Buying
GMAB98.03%0.00%
UTHR87.49%12.51%Net SellingNet Buying

Insmed Stock Ownership FAQ

Who owns Insmed?

Insmed (NASDAQ: INSM) is owned by 108.82% institutional shareholders, 20.73% Insmed insiders, and 0.00% retail investors. Richard S. Kollender is the largest individual Insmed shareholder, owning 21.92M shares representing 12.04% of the company. Richard S. Kollender's Insmed shares are currently valued at $2.28B.

If you're new to stock investing, here's how to buy Insmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.